
- Plasmaselect in Germany
- Eurogenerics in Belgium,
- EG Labo in France and
- EG S.p.A in Italy.
Source: Claris"We are hoping to clock first year's sales of about Rs 75 crore or 10% of the Rs 750 crore market for our products in these three countries", Sushil Handa, founder CEO said. Making a projection for the future.
Handa said that they are looking at capturing 28-30% of the total market share of these products, which includes Propofol and Anti-infectives.






Comment Preview